Source: The Lakeside, OR weather data displayed above is derived from the NOAA (National Oceanic and Atmospheric). Air quality and pollution data is derived from the EPA (United States Environmental Protection Agency).
DUBLIN, June 15, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced today that the 510(k) Premarket Notification Application for the XEN Glaucoma Treatment System (consisting of the XEN45 Gel Stent and the XEN Injector) has been accepted for filing by the U.S. Food and Drug Administration (FDA).
A search today Monday 25March 2013 on FDA web site for 510(k) clearance or PMA approved for VANQUISH indicates there is no registration, clearance, nor approval for this device. Your articles should be more clear on the FDA status of these devices so the public is not mislead. The ALLURE article is very misleading. Other manufacturers and distributors are in trouble with the FDA for promoting, selling, and distributing a device without FDA clearance nor approval.